Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial.
| Image |  |
|---|---|
| Description | scientific article published in December 2017 |
| Author/s |
author: Frederik Persson Rikke Borg |
| Publication date | December 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |